Prorok et al. (1999) [30] |
The detection of cancers that would never have been found were it not for the screening test |
Etzioni et al. (2003) [31] |
The detection of cancers that would otherwise not have been detected in the remaining life span of the individuals |
Zahl et al. (2004) [32] |
The detection of low malignancy lesions that otherwise would not be detected in a patient’s lifetime |
Day (2005) [33] |
Lesions that are detected at screening but which would not have surfaced clinically in the lifetime of the individual |
Moss (2005) [34] |
The diagnosis of invasive or in situ breast cancer that, in the absence of screening, would not have presented clinically during the woman's lifetime |
de Koning et al. (2006) [35] |
The detection of cancers by screening that would otherwise never have been clinically diagnosed but are now consequently treated |
Paci & Duffy (2005) [29] |
Diagnosis of cancer that would not have led to clinically manifested disease in a woman's lifetime, in the absence of screening |
Warren & Eleti (2006) [36] |
Diagnosis of cancers that would not present during the lifetime of the patient and is one of the downsides of screening |
Biesheuvel et al. (2007) [9] |
The detection with screening of cancer that would not have presented clinically during the ‘woman's lifetime (and therefore would not be diagnosed in the absence of screening)' |
Mandelblatt et al. (2009) [37] |
The proportion of cases in each strategy that would not have clinically surfaced in a woman's lifetime among all cases |
Duffy et al. (2010) [38] |
The diagnosis of a cancer as a result of screening that would not have been diagnosed in the ‘woman's lifetime had screening not taken place |
Welch & Black (2010) [4] |
The diagnosis of a “cancer” that would otherwise not go on to cause symptoms or death |
Seigneurin et al. (2011) [39] |
The proportion of non-progressive cancers among all cases of invasive cancer and carcinoma in situ
|
Gunsoy et al. (2012) [40] |
The diagnosis of screen detected cancers that would not have presented clinically in a lifetime in the absence of screening |
Hellquist et al. (2012) [16] |
The excess of cancers diagnosed with screening compared with without screening that is not due to earlier diagnosis |
Marmot (2012) [41] |
The diagnosis of cancer as a result of screening which would not have been diagnosed in the patient's lifetime had screening not taken place |
Puliti et al. (2012) [20] |
The detection of a cancer at screening, histologically confirmed, that would never have been identified clinically in the lifetime of the woman |
Yen et al. (2012) [42] |
The diagnosis of cancer as a result of screening that would not have arisen in the lifetime of the host |
Etzioni et al. (2013) [43] |
Excess cases detected because of cancer screening |
Miller (2013) [25] |
The detection by screening of a cancer not destined to present clinically in the person's lifetime |
Zahl et al. (2013) [24] |
The detection of lesions that would never have been detected in a persony in the lein the absence of screening |
Cervera et al. (2014) [28] |
The detection of a disease that would have gone undetected without screening when that disease would not have resulted in morbimortality and was treated unnecessarily |
Pace & Keating (2014) [44] |
The detection of a tumor through screening that would not have become clinically evident in the absence of screening |